CompletedNot Applicable

Exploring Long-term Risks and STI Prevalence in Pre-Exposure Prophylaxis Users in Gironde, France

France248 participantsStarted 2024-11-04

Plain-language summary

SAFER-PrEP investigates the long-term impact of Pre-Exposure Prophylaxis (PrEP) on risky sexual behaviors and Sexually Transmitted Infection (STI) prevalence among users in Aquitaine. The study aims to compare STI rates over the last three months between individuals on PrEP for over a year and those on PrEP for less than a year. This retrospective observational research offers insights into the evolving dynamics of sexual health practices, informing future PrEP prescriptions and enhancing preventive strategies.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Aged over 18 years old; * Participants using PrEP for at least 6 months ; * French-speaking, without comprehension disorders ; * being affiliated to health insurance ; * Willing to participate and to sign informed consent. Exclusion Criteria: * Individuals with known HIV positivity;

What they're measuring

Prevalence of Sexually Transmitted Infections (STIs) within the last three months

Timeframe: At baseline (Day 0)

Trial details

NCT IDNCT06600087

SponsorUniversity Hospital, Bordeaux

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-06-03

View on ClinicalTrials.gov More HIV Infections trials